In the study by Dispenzieri et al.  the prevalence and risk of progression of light chain MGUS amongst 18,357 residents of Olmstead County, Minnesota aged 50 years or older was assessed. 610 (3.3%) individuals had an abnormal κ/λ sFLC ratio, of whom 213 had an intact immunoglobulin MGUS. This included 57/213 additional patients whose monoclonal intact immunoglobulin had not previously been detected by screening with SPE, and so the prevalence of conventional MGUS in this population was revised from 3.2% to 3.4% (95% CI 3.2 - 3.7). Of the 397 individuals with an abnormal sFLC ratio but no abnormality detected by SPE, a total of 146 met the definition of light chain MGUS, equivalent to a prevalence of 0.8% (95% CI 0.7 - 0.9). This represented 19% of the total MGUS population; a proportion that matches the relative incidence of LCMM compared to all MM. The light chain type was identified as κ or λ in 108 and 38 individuals, respectively. Overall, involved sFLC concentrations tended to be low; only around 10% of patients had concentrations greater than 200 mg/L. It was noted that 23% of light chain MGUS patients either had or subsequently acquired, renal disease; an observation of relevance to the later proposal for monoclonal gammopathy of renal significance to be considerd as a separate entity (Section 26.4.1). A similar incidence of light chain MGUS (0.7%) was confirmed by a European study of 4702 individuals aged 45 - 75 years .
Although a coexisting abnormal κ/λ sFLC ratio increased the risk of progression to MM and related disorders for patients with conventional MGUS, risk of progression of light chain MGUS did not differ from that for patients with low-risk conventional MGUS (i.e. those with no abnormal κ/λ sFLC ratio) (p=0.1822) . Dispenzieri et al.  speculated that the transformation events resulting in either light chain MGUS or conventional MGUS may be the same, and that the presence of an abnormal sFLC ratio in patients with conventional MGUS indicate that two transformation events had occured and their disease was one step closer to malignant transformation.